Advanced search

News (62)

Transcript : DSV A/S, 2023 Earnings Call, Feb 01, 2024	01/02
DSV, 1088 - DSV announces changes to the Executive Board and the Group Executive Committee	01/02	GL
DSV A/S Announces Executive Changes	01/02	CI
Relesys reports 36% year-on-year growth in Annual recurring revenue in Q3 2023. Relesys keeps guidance unchanged.	29/11	AQ
Relesys reports 46% year-on-year growth in Annual Recurring Revenue in Q1 2023. Relesys keeps guidance unchanged.	11/23/11	AQ
ALK Abelló A/S : Annual General Meeting 2023 Minutes	29/23/29	PU
Transcript : ALK-Abelló A/S - Shareholder/Analyst Call	23/23/23
ALK Abelló A/S : Notice convening the AGM	24/23/24	PU
Upward adjustment of ARR guidance for 2022.	06/22/06	AQ
Relesys reports 36% year-on-year growth in Annual Recurring Revenue in Q3 2022. ARR and Revenue Guidance Range narrowed.	30/22/30	AQ
Changes to the Board of Directors of Relesys A/S	22/22/22	AQ
Relesys reports 40% year-over-year growth in Annual Recurring Revenue in H1 2022.	30/22/30	AQ
Transcript : DSV A/S - Analyst/Investor Day	31/22/31
Relesys realizes 33% year-over-year growth in Annual Recurring Revenue in Q1 2022.	25/22/25	AQ
Relesys A/S announces results of the Annual General Meeting 2022	27/22/27	AQ
Netflix : Danish Series Baby Fever Launches on Netflix June 8 - Watch the First Teaser →	22/22/22	PU
Notice of Annual General Meeting of Relesys A/S	12/22/12	AQ
Relesys A/S: Notiﬁcation of transactions by persons discharging managerial responsibilities and persons closely associated with them	01/22/01	AQ
Relesys A/S realizes growth in Annual Recurring Revenue of 40% in 2021	28/22/28	AQ
Netflix : Baby Fever – A New Danish Netflix Series About Fertility Treatment, Choices, Parenthood And Love →	22/22/22	PU
Known data from a pilot study that tested an early version the Brain+ Computerized Cognitive Training technology in Parkinson's Disease has been published	18/22/18	AQ
Transcript : DSV A/S, Q1 2019 Earnings Call, Apr 30, 2019	30/19/30
DSV : Innovation Lab is designed to ensure DSV's competitiveness	13/18/13	PU
DSV : 83,000 m2 warehouse space for consumer brands	31/18/31	PU
A triple win: best CEO, CFO and now CIO	07/18/07	PU
DBAG Expansion Capital Fund managed by Deutsche Beteiligungs AG (DB:DBAN) completed the acquisition of 52.1% stake in Sjølund A/S from Chief Executive Officer of Sjølund, Søren Ravn Jensen.	31/18/31	CI
DBAG Expansion Capital Fund managed by Deutsche Beteiligungs AG (DB:DBAN) agreed to acquire 51% stake in Sjølund A/S from Chief Executive Officer of Sjølund, Søren Ravn Jensen.	09/18/09	CI
The future is beckoning: We must be willing to change	27/17/27	PU
Transcript : Novo Nordisk A/S, Q1 2017 Earnings Call, May 04, 2017	04/17/04
Transcript : Novo Nordisk A/S, Q1 2017 Earnings Call, May 03, 2017	03/17/03
Transcript : Novo Nordisk A/S - Shareholder/Analyst Call	23/17/23
Transcript : Novo Nordisk A/S, Q4 2016 Earnings Call, Feb 06, 2017	06/17/06
Transcript : Novo Nordisk A/S, Q4 2016 Earnings Call, Feb 02, 2017	02/17/02
Transcript : Novo Nordisk A/S, Q3 2016 Earnings Call, Oct 28, 2016	28/16/28
Transcript : Novo Nordisk A/S - Special Call	01/16/01
Novo Nordisk A/S : Lars Rebien Sørensen to retire as CEO of Novo Nordisk; Lars Fruergaard Jørgensen appointed as successor	01/16/01	GL
Novo Nordisk A/S Announces Management Changes	01/16/01	CI
Transcript : Novo Nordisk A/S, Q2 2016 Earnings Call, Aug 05, 2016	05/16/05
Transcript : Novo Nordisk A/S, Q1 2016 Earnings Call, Apr 29, 2016	29/16/29
Novo Nordisk A/S : Trading in Novo Nordisk shares by board members, executives and associated persons on 1 April 2016	04/16/04	PU
Transcript : Novo Nordisk A/S - Shareholder/Analyst Call	18/16/18
Transcript : Novo Nordisk A/S - Special Call	24/16/24
Transcript : Novo Nordisk A/S, 2015 Earnings Call, Feb 03, 2016	03/16/03
Transcript : Novo Nordisk A/S - Analyst/Investor Day	19/15/19
Transcript : Novo Nordisk A/S, Q3 2015 Earnings Call, Oct 30, 2015	30/15/30

12NextSee all

Companies (2)

JIANGSU RIYING ELECTRONICS CO.,LTD. 290 M $

Jiangsu Riying Electronics Co Ltd is a China-based company mainly engaged in research and development, production and sales of auto parts. The company's products are divided into sensing products, transmission products, control products and others. The se ...

REX INTERNATIONAL HOLDING LIMITED 120 M $

Rex International Holding Limited is a Singapore-based multinational oil exploration and production (E&P) company. The Company has interests in exploration production licenses in Oman, Norway and Malaysia, and holds operatorship for the assets in Oman and ...

Insiders

Jesper Riis

Jesper Riis holds the position of Group Chief Information Officer at DSV Panalpina A.

John Riis

Per Johan Riis

Bente Juel Riis

Bente Juel Riis is the founder of Nordic Bioscience A, which was founded in 1989.
She held the title of Director at the company.
She received an undergraduate degree from the University of Copenhagen in 1981.

Jakob Riis

Jakob Riis is currently the President & Chief Executive Officer at Falck A, the Chief Executive Officer & Director at Falck Danmark A, the Chief Executive Officer at Adelca ApS, and the Chairman at Falck Health Care Holding A.
He is also the Chairman of Falck Healthcare A, Copenhagen Institute of Interaction Design Aps, and a Non-Independent Director at H.
Lundbeck A.
Additionally, he serves as a Director at Dansk Erhverv and Response AS.
Previously, he held positions as a Director at Copenhagen Capacity, ALK-Abello A, and Novo Nordisk A, where he was the EVP & Head-North America Operations.
He also served as the President of Novo Nordisk, Inc. Dr. Riis obtained a graduate degree from the University of Copenhagen in 1993 and a doctorate degree from the same institution in 1998.

Henrik Riis

Bjarne Riis

Lars Riis

Lars Riis was previously employed as the Head of Training at DAT A.

Lasse Riis

Stian Riis

No results for this search